Posts With Tag NASDAQ REGN

Showing 1 - 2 of 2 Posts

Regeneron Pharmaceuticals 8-K Report: Key Developments for Investors

•

8-K

•

2025-10-28

Last updated: about 1 month ago

Regeneron Pharmaceuticals 8-K Report: Key Developments for Investors

Explore Regeneron Pharmaceuticals' 8-K filing from October 28, 2025, detailing crucial updates. Learn more about stock performance and regulatory compliance.

Regeneron Pharmaceuticals biotechnology NASDAQ REGN financial reporting 8-K filing

Regeneron Pharmaceuticals 8-K Report: Latest Updates on Compliance & Stock Performance

•

8-K

•

2025-06-18

Last updated: 5 months ago

Regeneron Pharmaceuticals 8-K Report: Latest Updates on Compliance & Stock Performance

Discover Regeneron Pharmaceuticals' June 13, 2025, 8-K filing, detailing key corporate events and stock info essential for investors.

Regeneron Pharmaceuticals biotechnology NASDAQ REGN 8-K filing investor relations